Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment

Clinical trial NCT03633227 · TERMINATED

Trial details

NCT number: NCT03633227
Sponsor: Intercept Pharmaceuticals
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Liver Cirrhosis, Biliary

Start date: 2018-06-22
Primary completion: 2021-07-09
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.